Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Two of Trump's top health nominees faced Senate scrutiny on vaccines, abortion pills, and food safety. FDA commissioner nominee Heidi Overton and surgeon general nominee Nicole Saphier both affirmed that approved vaccines are safe and effective — but critics say neither went far enough in pushing back on the administration's anti-vaccine messaging. Both nominations now await a committee vote before heading to the full Senate.
The Senate HELP Committee put two of President Trump's top health nominees through their paces in back-to-back hearings. FDA commissioner nominee Heidi Overton, MD (Sept. 24) and surgeon general nominee Nicole Saphier, MD (Sept. 17) both faced pointed questions on vaccines, mifepristone safety, and food security — with senators on both sides of the aisle pressing for clearer commitments.
On vaccines, both nominees affirmed that FDA-approved vaccines — including the MMR — are safe and effective. But neither directly corrected the president's public statements casting doubt on vaccine safety. Overton framed Trump's push for vaccine alternatives as an effort to reach hesitant Americans post-COVID; Saphier said she believes "vaccines save lives" but stopped short of forcefully defending the childhood immunization schedule. On mifepristone, both pointed to ongoing FDA safety reviews rather than endorsing the drug's well-established safety record outright.
Medical ethicist Arthur Caplan, PhD, of NYU was direct in his assessment: both nominees gave responses that fell short of the science-based advocacy the moment demands — particularly amid active measles outbreaks and a 35%+ drop in overseas FDA food facility inspections.
Why it matters: The FDA commissioner and surgeon general are two of the most influential voices in American public health. How these nominees navigate the tension between political loyalty and scientific integrity will shape vaccine policy, drug safety decisions, and food oversight for years to come.
